The Effect of Yoga Interventions on Cancer-Related Fatigue and Quality of Life for Women with Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

breast cancer cancer-related fatigue meta-analysis physical activity quality of life systematic review yoga

Journal

Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834

Informations de publication

Date de publication:
Historique:
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 19 8 2021
Statut: ppublish

Résumé

Women with breast cancer (BC) are living longer with debilitating side effects such as cancer-related fatigue (CRF) that affect overall well-being. Yoga promotes health, well-being and may be beneficial in reducing CRF. Although there have been previous systematic reviews and meta-analyses, the effects of yoga on CRF and quality of life (QOL) remain unclear, particularly in comparison with other types of physical activity (PA). Our objective is to carry out a systematic review and meta-analysis of the effects of yoga on CRF and QOL in women with BC. Electronic databases were searched (MEDLINE, Embase Classic+Embase and EMB Reviews, Cochrane Central CT) from inception to May 2018. Randomized controlled trials were included if they were full text, in English, included a yoga intervention, a comparator (including non-PA usual care or alternate PA intervention), and reported on CRF or QOL. Effects of yoga were pooled using standardized mean difference (SMD) via a random effects model. Of the 2468 records retrieved, 24 trials were included; 18 studies compared yoga to a non-PA comparator and 6 to a PA comparator. Yoga demonstrated statistically significant improvements in CRF over non-PA (SMD -0.30 [-0.51; -0.08]) but not PA (SMD -0.17 [-0.50; 0.17]) comparators. Additionally, yoga demonstrated statistically significant improvements in QOL over non-PA (SMD -0.27 [-0.46; -0.07]) but not PA (SMD 0.04 [-0.22; +0.31]) comparators. This meta-analysis found that yoga provides small to medium improvements in CRF and QOL compared to non-PA, but not in comparison to other PA interventions.

Sections du résumé

BACKGROUND
Women with breast cancer (BC) are living longer with debilitating side effects such as cancer-related fatigue (CRF) that affect overall well-being. Yoga promotes health, well-being and may be beneficial in reducing CRF. Although there have been previous systematic reviews and meta-analyses, the effects of yoga on CRF and quality of life (QOL) remain unclear, particularly in comparison with other types of physical activity (PA). Our objective is to carry out a systematic review and meta-analysis of the effects of yoga on CRF and QOL in women with BC.
METHODS
Electronic databases were searched (MEDLINE, Embase Classic+Embase and EMB Reviews, Cochrane Central CT) from inception to May 2018. Randomized controlled trials were included if they were full text, in English, included a yoga intervention, a comparator (including non-PA usual care or alternate PA intervention), and reported on CRF or QOL. Effects of yoga were pooled using standardized mean difference (SMD) via a random effects model.
RESULTS
Of the 2468 records retrieved, 24 trials were included; 18 studies compared yoga to a non-PA comparator and 6 to a PA comparator. Yoga demonstrated statistically significant improvements in CRF over non-PA (SMD -0.30 [-0.51; -0.08]) but not PA (SMD -0.17 [-0.50; 0.17]) comparators. Additionally, yoga demonstrated statistically significant improvements in QOL over non-PA (SMD -0.27 [-0.46; -0.07]) but not PA (SMD 0.04 [-0.22; +0.31]) comparators.
DISCUSSION
This meta-analysis found that yoga provides small to medium improvements in CRF and QOL compared to non-PA, but not in comparison to other PA interventions.

Identifiants

pubmed: 33073636
doi: 10.1177/1534735420959882
pmc: PMC7580184
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1534735420959882

Références

Clin Oncol (R Coll Radiol). 2010 Apr;22(3):208-21
pubmed: 20110159
J Altern Complement Med. 2010 Jan;16(1):3-12
pubmed: 20105062
Br J Cancer. 2017 Nov 7;117(10):1442-1449
pubmed: 28926526
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145
pubmed: 23152233
Geburtshilfe Frauenheilkd. 2013 Apr;73(4):311-317
pubmed: 24771916
Asia Pac J Clin Oncol. 2017 Apr;13(2):e79-e95
pubmed: 25560636
Disabil Rehabil. 2013;35(24):2038-45
pubmed: 23772995
J Nurs Res. 2014 Sep;22(3):155-64
pubmed: 25111109
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2012;7(4):e34916
pubmed: 22514690
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
J Phys Act Health. 2015 May;12(5):675-9
pubmed: 24834485
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
Cancer Control. 2005 Jul;12(3):165-71
pubmed: 16062164
Support Care Cancer. 2012 Dec;20(12):3055-64
pubmed: 23052917
Explore (NY). 2013 Jul-Aug;9(4):232-43
pubmed: 23906102
Evid Based Complement Alternat Med. 2016;2016:5931816
pubmed: 27019663
Evid Based Complement Alternat Med. 2012;2012:124703
pubmed: 22991569
Eur J Cancer Care (Engl). 2010 Nov;19(6):761-8
pubmed: 19832890
Cancer Nurs. 2007 Sep-Oct;30(5):E35-45
pubmed: 17876176
J Natl Compr Canc Netw. 2010 Dec;8(12):1331-9
pubmed: 21147900
Br J Sports Med. 2018 May;52(10):651-658
pubmed: 28501804
Support Care Cancer. 2016 Sep;24(9):4005-15
pubmed: 27129840
Complement Ther Clin Pract. 2015 Feb;21(1):7-10
pubmed: 25697379
J Clin Oncol. 2007 Oct 1;25(28):4387-95
pubmed: 17785709
Phys Ther. 2010 Aug;90(8):1135-47
pubmed: 20558566
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
BMC Cancer. 2012 Nov 27;12:559
pubmed: 23181734
Cancer. 2015 Jul 1;121(13):2175-84
pubmed: 25739642
J Cancer Res Clin Oncol. 2016 Dec;142(12):2523-2540
pubmed: 27630024
Cancer. 2012 Apr 15;118(8 Suppl):2261-9
pubmed: 22488700
J Racial Ethn Health Disparities. 2018 Feb;5(1):62-72
pubmed: 28411330
Am J Phys Med Rehabil. 2014 Aug;93(8):675-86
pubmed: 24743466
ScientificWorldJournal. 2014 Jan 19;2014:271828
pubmed: 24563628
Psychooncology. 2013 Jan;22(1):186-94
pubmed: 23296635
BMC Complement Altern Med. 2014 Jul 01;14:214
pubmed: 24980836
Ann Oncol. 2009 Jan;20(1):17-25
pubmed: 18678767
Psychooncology. 2009 Apr;18(4):360-8
pubmed: 19242916
Complement Ther Med. 2009 Oct-Dec;17(5-6):274-80
pubmed: 19942107
Support Care Cancer. 2018 Mar;26(3):905-912
pubmed: 28965138
Acta Oncol. 2011 Feb;50(2):187-93
pubmed: 21231780
Crit Rev Oncol Hematol. 2018 Feb;122:52-59
pubmed: 29458789
Am Surg. 2010 Sep;76(9):962-5
pubmed: 20836343
Glob Adv Health Med. 2012 Nov;1(5):30-5
pubmed: 27257529
J Clin Oncol. 2014 Apr 1;32(10):1040-9
pubmed: 24470004
J Soc Integr Oncol. 2010 Spring;8(2):43-55
pubmed: 20388445
J Am Acad Nurse Pract. 2011 Mar;23(3):135-42
pubmed: 21355946
Evid Based Complement Alternat Med. 2011;2011:659876
pubmed: 21437197
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Prz Menopauzalny. 2014 Jun;13(3):186-93
pubmed: 26327853
Cancer. 2012 Aug 1;118(15):3766-75
pubmed: 22180393
Cancer Nurs. 2011 Jul-Aug;34(4):322-34
pubmed: 21116178
Psychooncology. 2006 Oct;15(10):891-7
pubmed: 16374892
JAMA Oncol. 2017 Jul 1;3(7):961-968
pubmed: 28253393
Support Care Cancer. 2012 Feb;20(2):267-77
pubmed: 21207071
Integr Cancer Ther. 2015 Mar;14(2):125-32
pubmed: 25567329
J Clin Oncol. 2014 Apr 1;32(10):1058-65
pubmed: 24590636
Indian J Palliat Care. 2017 Jul-Sep;23(3):247-252
pubmed: 28827926

Auteurs

Meagan O'Neill (M)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Dominic Samaroo (D)

University Health Network, Toronto, ON, Canada.

Christian Lopez (C)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

George Tomlinson (G)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Daniel Santa Mina (D)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Catherine Sabiston (C)

University of Toronto, Toronto, ON, Canada.

Nicole Culos-Reed (N)

University of Calgary, Calgary, AB, Canada.

Shabbir M H Alibhai (SMH)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH